🇺🇸 FDA
Patent

US 6911471

S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer

expired A61PA61P35/00A61P35/02

Quick answer

US patent 6911471 (S-dimethylarsino-thiosuccinic acid s-dimethylarsino-2-thiobenzoic acid s-(dimethylarsino) glutathione as treatments for cancer) held by The Board of Regents of the University of Texas System expires Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jun 28 2005 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jun 23 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
40
CPC classes
A61P, A61P35/00, A61P35/02